Evidence map›Paper›PMID 34509158›Full record

ArticleStem cell research2021

Polyvinyl alcohol hydrolysis rate and molecular weight influence human and murine HSC activity ex vivo.

Kazuhiro Sudo, Satoshi Yamazaki, Adam C Wilkinson, Hiromitsu Nakauchi, Yukio Nakamura

Open access · goldAbstract read
In one paragraph

Article in Stem cell research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. FACS-Based Assessment of Human Hematopoietic Stem and Progenitor Cells.International journal of molecular sciences · 2025
    Review
  3. Article
  4. Review
  5. Advances in HIV Gene Therapy.International journal of molecular sciences · 2024
    Review
  6. Review
  7. Recent advances inBlood cell therapy · 2023
    Article
  8. Article
  9. Article
  10. Linking cell cycle to hematopoietic stem cell fate decisions.Frontiers in cell and developmental biology · 2023
    Review
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Kazuhiro SudoCell Engineering Division, BioResource Research Center, RIKEN, Tsukuba, Japan. Electronic address: kazuhiro.sudo@riken.jp.
Satoshi YamazakiDivision of Stem Cell Therapy, Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; Laboratory of Stem Cell Therapy, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan. Electronic address: y-sato4@md.tsukuba.ac.jp.
Adam C WilkinsonMRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, UK.
Hiromitsu NakauchiDivision of Stem Cell Therapy, Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; Institute for Stem Cell Biology and Regenerative Medicine and Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.
Yukio NakamuraCell Engineering Division, BioResource Research Center, RIKEN, Tsukuba, Japan.
RIKEN BioResource Research Center · JPStanford University · USUniversity of Oxford · GBUniversity of Tsukuba · JP

Funding

Valine as a Metabolic Modulator of HematopoiesisR01DK116944 · NIDDK · STANFORD UNIVERSITY · PI NAKAUCHI, HIROMITSU · 2018 to 2021
$1.5M
A synthetic hematopoietic stem cell niche to investigate stemness and hematopathologiesK99HL150218 · NHLBI · STANFORD UNIVERSITY · PI WILKINSON, ADAM C · 2020 to 2020
$167k
Medical Research Council MC_UU_00016/18NHLBI NIH HHS K99 HL150218NIDDK NIH HHS R01 DK116944
6 · The paper itself

Abstract

Ex vivo expansion of hematopoietic stem cells (HSCs) is one of the most promising strategies to increase the availability of transplantable HSCs and improve bone marrow transplantation outcomes. We recently demonstrated that mouse HSCs could be efficiently expanded in polyvinyl alcohol (PVA)-containing culture medium using only recombinant stem cell factor and thrombopoietin cytokines. However, the behavior of human HSCs in these simple PVA-based media was not fully elucidated. In this study, we analyzed the compatibility of PVA of different hydrolysis rates (HR) and molecular weights (MW) to support functional human and mouse HSCs ex vivo. Human and mouse HSCs proliferated more frequently in media containing PVA with lower HR than with higher HR, but both PVA types supported HSC multilineage reconstitution potential. Importantly, human HSCs cultured in PVA-containing media engrafted not only in irradiated recipients but also in non-irradiated recipients. Our results demonstrate that human HSCs can be maintained ex vivo using PVA-based culture systems and suggest approaches for future optimization of human HSC expansion.

Indexed as

Hematopoietic Stem Cell TransplantationPolyvinyl AlcoholAnimalsCells, CulturedCytokinesHematopoietic Stem CellsHumansHydrolysisMiceMolecular WeightCytokinesPolyvinyl AlcoholEx vivo expansionHematopoietic stem cellNon-conditioned recipientPolyvinyl alcoholTransplantation

Identifiers

PMID34509158
PMCPMC8629160
OpenAlexW3196800853

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.